The 6th Annual CEND Symposium. Academia and the Global Health Pipeline: Basic Science Innovation and Translation
Friday, January 10, 2014 from 9:00 AM to 6:00 PM (PST)
San Francisco, California
London, United Kingdom
Emerging and neglected diseases are a group of debilitating and often deadly infections. As a group, these diseases are poorly understood and generally lack effective tools for prevention, control, and treatment. The Henry Wheeler Center for Emerging & Neglected Diseases (CEND) Annual Symposium aims to strengthen connections between San Francisco Bay Area scientists working on infectious diseases of global health importance and the broader global health research, product development, and advocacy communities. The theme for the 2014 symposium is, “Academia and the Global Health Pipeline: Basic Science, Innovation, and Translation.”
Academia and the Global Health Pipeline: Basic Science, Innovation, and Translation Friday January 10th, 2014 — 9:00 am to 5:00 pm UC Berkeley, Li Ka Shing Center Auditorium, Room 245
Confirmed Speakers Include:
Norma Andrews, University of MarylandNew Insights into the Intracellular Life Style of Trypanosomatid Parasites
William Bishai, University of Kwa Zulu-Natal, Durban, South Africa
TB Pathogenesis: Subversion by Small Molecules
Fidelis Cho-Ngwa, University of Buea, Cameroon
Onchocerciasis: State of Chemotherapy and Drug Discovery Activities at the ANDI Centre of Excellence, University of Buea, Cameroon
Alan Cowman, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Understanding how the Malaria Parasite Invades and Renovates the Human Red Blood Cell
Warner Greene, The Gladstone Institutes of Virology and Immunology
Depletion of CD4 T Cells in HIV Infection is Mainly a Suicide, Not a Murder
Steve Kern, Bill & Melinda Gates Foundation
Accelerating Global Health Innovations toward Real Solutions in the Field
The symposium will also feature a panel discussion on the topic of engaging academia in global health product development. Panelists include Eric Easom, Vice President of Neglected Diseases Drug Discovery at Anacor Pharmaceuticals, Ponni Subbiah, Global Program Leader of Drug Development at PATH, and Tom Dubensky, Chief Scientific Officer at Aduro BioTech.
New to this year's symposium is a poster session to complement the exciting line-up of plenary speakers. Participants are encouraged to present posters in the areas of epidemiology, basic sciences and translational research related to emerging and neglected disease. Space is limited for poster presentations. To be considered for a poster presentation, please register and submit your poster abstract by December 18th, 2013. General registration will close January 6th, 2014.
When & Where
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)
The Henry Wheeler Center for Emerging & Neglected Diseases (CEND) was established as a multi-disciplinary research unit at the University of California, Berkeley, in 2008, with the support of a generous donation by Henry H. “Sam” Wheeler, Jr. The mission of CEND is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. We at CEND believe that by educating potential innovators, connecting researchers from diverse disciplines, and investing in research, we can help the best and brightest minds at UC Berkeley access the resources they need to make meaningful and innovative contributions to our scientific understanding and ability to combat emerging and neglected diseases.